
Allen C Ho MD FACS
Retinal Disease
Director of Retina Research Wills Eye Hospital Professor of Ophthalmology, Jefferson Medical College
Join to view full profile
840 Walnut StFl 10Philadelphia, PA 19107
Phone+1 800-331-6634
Fax+1 215-825-2443
Dr. Ho is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allen Ho is an ophthalmologist based in Philadelphia, PA, specializing in retinal disease. He completed his education at Columbia University and trained in ophthalmology at Thomas Jefferson University/Wills Eye Hospital. Dr. Ho is the Director of Retina Research at Wills Eye Hospital and holds academic positions at Thomas Jefferson University. His expertise includes translational clinical trials, cell and gene therapies, surgical retinal disease, diabetes mellitus, diabetic retinopathy, and macular degeneration. He has contributed numerous publications to prominent ophthalmology journals. He has participated in several clinical trials related to retinal health. Dr. Ho has been recognized as one of the most influential ophthalmologists and consistently listed as a top doctor by various organizations.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1989 - 1992
Atlantic HealthInternship, Internal Medicine, 1988 - 1989
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
NJ State Medical License 1997 - 2027
PA State Medical License 1990 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- 100 Most Influential Ophthalmologists in the World The Ophthalmologist, 2019-2023
- Top Docs of Philadelphia Philadelphia Magazine, 2008-2023
- America's Top Doctors Castle Connolly, 2008-2023
Clinical Trials
Publications & Presentations
PubMed
- Pilot Clinical Trial of Topical Netarsudil to Lower Risk of Proliferative Vitreoretinopathy in High-Risk Primary Retinal Detachment.Bita Momenaei, Roselind Ni, Jingwen Zhang, Yoshihiro Yonekawa, Ajay E Kuriyan
Journal of Vitreoretinal Diseases. 2026-08-06 - Readability of Retina Patient Education Materials Generated With a Large Language Model.Turner D Wibbelsman, Martin Calotti, Randy Calotti, Mak Djulbegovic, Nikhil Bommakanti
Journal of Vitreoretinal Diseases. 2026-05-20 - Clinical Outcomes of Ocular Toxoplasmosis-Associated Rhegmatogenous and Tractional Retinal Detachment.Mélanie Hébert, Holden Caplan, Michael D Yu, Taku Wakabayashi, Jordan D Deaner
Journal of Vitreoretinal Diseases. 2026-05-13
Press Mentions
Nanoscope Announces 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis PigmentosaOctober 22nd, 2025
Geographic Atrophy Therapies to WatchDecember 14th, 2024
Evidence of Durable Vision Improvement with Gene Therapy for Retinitis PigmentosaOctober 22nd, 2024
Professional Memberships
- Fellow
- Retina SocietyExecutive Board
- Macula SocietyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









